Immunome Reports 53% ORR in 19 B-NHL Patients
At the June 26, 2026 interim cutoff, 10 of 19 response-evaluable B-NHL patients had an overall response, including five complete and five partial responses. In the 11-patient DLBCL subgroup, ORR was 64% (7/11).
At the interim data cutoff of June 26, 2026, 19 response-evaluable B-NHL patients had a 53% ORR (10/19), including five complete and five partial responses; among 11 DLBCL patients, ORR was 64% (7/11).Material DetailsContext by AI AnalystThis is an early interim readout from an ongoing Phase 1 stud…